Showing results (21-30 of 160) with videos related to
Sort By:
Pageof 16
Pharmacology, Biochemistry, and Behavior|January 1, 1987
Naloxone sensitivity in squirrel monkeys under a schedule of shock titrationA H Oliveto, L A DykstraThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1985
Effects of picenadol (LY150720) and its stereoisomers on electric shock titration in the squirrel monkeyR B Carter, L A DykstraPsychopharmacology|April 2, 1999
The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in ratsR M Allen, L A DykstraThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioidsK R Powell, L A DykstraThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration scheduleR M Craft, L A DykstraThe Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitudeR M Allen, L A DykstraBehavioural Pharmacology|September 9, 2005
The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)S J Ward, L A DykstraPsychopharmacology|January 1, 1988
Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonistsA H Oliveto, L A DykstraThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine outputR M Craft, L A DykstraThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatmentR M Craft, L A DykstraPageof 16